Search research articles
Contact Us
Filters
Showing results (461-470 of 484) with videos related to
Page
of 49
Sort By:
The New England Journal of Medicine
|
August 30, 2016
CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea
R Doug McEvoy, Nick A Antic, Emma Heeley, et al.
Journal of Health, Population, and Nutrition
|
November 4, 2025
Availability, healthiness and sodium content of packaged and unpackaged foods and beverages in nigeria: a cross-sectional study
Adedayo E Ojo, Katrina R Kissock, Alexandra Jones, et al.
Circulation
|
February 8, 2021
Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE Trial
Nan Ye, Meg J Jardine, Megumi Oshima, et al.
European Journal of Preventive Cardiology
|
October 6, 2011
International collaborative project to compare and monitor the nutritional composition of processed foods
Elizabeth Dunford, Jacqui Webster, Adriana Blanco Metzler, et al.
The New England Journal of Medicine
|
August 30, 2021
Effect of Salt Substitution on Cardiovascular Events and Death
Bruce Neal, Yangfeng Wu, Xiangxian Feng, et al.
Frontiers in Nutrition
|
April 13, 2026
Assessing the implementation of national sodium reduction policies in Nigeria: an interim qualitative evaluation of stakeholder perspectives
Chisom Obiezu-Umeh, Vanessa Alfa, Clementina E Okoro, et al.
Clinical Kidney Journal
|
January 19, 2026
Cardiac impact of dapagliflozin in advanced chronic kidney disease: rationale and design of the Renal Lifecycle Trial cardiac imaging sub-studies
Micky Karsten, Sunil V Badve, Ron T Gansevoort, et al.
JAMA
|
November 7, 2025
Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria: A Meta-Analysis
Natalie Staplin, Alistair J Roddick, Brendon L Neuen, et al.
The Lancet. Diabetes & Endocrinology
|
July 11, 2024
Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials
Ellen M Apperloo, Brendon L Neuen, Robert A Fletcher, et al.
JAMA
|
November 7, 2025
SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Meta-Analysis
Brendon L Neuen, Robert A Fletcher, Stefan D Anker, et al.
Page
of 49
Search research articles
Search
Showing results (461-470 of 484) with videos related to
Sort By:
Page
of 49
The New England Journal of Medicine
|
August 30, 2016
CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea
R Doug McEvoy, Nick A Antic, Emma Heeley, et al.
Journal of Health, Population, and Nutrition
|
November 4, 2025
Availability, healthiness and sodium content of packaged and unpackaged foods and beverages in nigeria: a cross-sectional study
Adedayo E Ojo, Katrina R Kissock, Alexandra Jones, et al.
Circulation
|
February 8, 2021
Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE Trial
Nan Ye, Meg J Jardine, Megumi Oshima, et al.
European Journal of Preventive Cardiology
|
October 6, 2011
International collaborative project to compare and monitor the nutritional composition of processed foods
Elizabeth Dunford, Jacqui Webster, Adriana Blanco Metzler, et al.
The New England Journal of Medicine
|
August 30, 2021
Effect of Salt Substitution on Cardiovascular Events and Death
Bruce Neal, Yangfeng Wu, Xiangxian Feng, et al.
Frontiers in Nutrition
|
April 13, 2026
Assessing the implementation of national sodium reduction policies in Nigeria: an interim qualitative evaluation of stakeholder perspectives
Chisom Obiezu-Umeh, Vanessa Alfa, Clementina E Okoro, et al.
Clinical Kidney Journal
|
January 19, 2026
Cardiac impact of dapagliflozin in advanced chronic kidney disease: rationale and design of the Renal Lifecycle Trial cardiac imaging sub-studies
Micky Karsten, Sunil V Badve, Ron T Gansevoort, et al.
JAMA
|
November 7, 2025
Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria: A Meta-Analysis
Natalie Staplin, Alistair J Roddick, Brendon L Neuen, et al.
The Lancet. Diabetes & Endocrinology
|
July 11, 2024
Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials
Ellen M Apperloo, Brendon L Neuen, Robert A Fletcher, et al.
JAMA
|
November 7, 2025
SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Meta-Analysis
Brendon L Neuen, Robert A Fletcher, Stefan D Anker, et al.
Page
of 49